Up a level |
Corrie, PG, Marshall, A, Nathan, PD, Lorigan, P, Gore, M, Tahir, S, Faust, G, Kelly, CG, Marples, M, Danson, SJ et al (show 28 more authors)
(2019)
Adjuvant bevacizumab for melanoma patients at high risk of recurrence: survival analysis of the AVAST-M trial (vol 29, pg 1843, 2018).
ANNALS OF ONCOLOGY, 30 (12).
pp. 2013-2014.
Holt, G, Lodge, J, McCarthy, AJ, Graham, A, Young, G, Bridge, S, Brown, A, Veses-Garcia, M, Lanyon, CV, Sails, A et al (show 2 more authors)
(2017)
Shigatoxin encoding bacteriophage ɸ24B modulates bacterial metabolism to raise antimicrobial tolerance.
Scientific Reports, 7 (1).
40424-.